California, US-based innovative diabetes management startup Glooko landed $7 million in a funding round led by Samsung Venture Investment Company and Lifeforce Ventures to expand its predictive diabetes care service.
Tags: FDA
AstraZeneca's ovarian cancer drug gets U.S. approval
AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.
FDA says expects China to OK staff visas after two-year delay
The U.S. Food and Drug Administration said on Friday it expects China, after almost two years of delays, to soon approve visas that will allow the agency to more than double its staff in China.
NutraSweet to exit artificial sweetener aspartame business
Artificial sweetener maker NutraSweet Co said on Wednesday it would exit its aspartame business by the end of the year, citing increasing foreign competition.
23andMe lands $1.4 million grant from NIH to detect genetic roots for disease
Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.
Latest News
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
Friday is the first day of sales for Sony's PlayStation 4 interactive gaming console. GE holds an meeting for investors and analysts focused on its GE Capital business. The Federal Reserve releases its report on U.S. industrial production.
Warner Chilcott has received FDA approval for oral contraceptive LO Minastrin FE. LO Minastrin FE, a chewable oral contraceptive made by Warner Chilcott PLC, has received the stamp of approval from the US Food and Drug Administration.
